期刊文献+

难治性特发性血小板减少性紫癜应用长春地辛及白介素-11的疗效分析 被引量:2

下载PDF
导出
摘要 目的探讨应用长春地辛及白介素-11治疗难治性特发性血小板减少性紫癜的疗效分析。方法将患者随机分为观察组与对照组,各42例。对照组患者接受肾上腺糖皮质激素、雄激素达那唑、大剂量丙种球蛋白等治疗。观察组则在对照组的基础上,加用长春地辛及白介素-11。其中长春地辛为静脉滴注,白介素-11皮下注射,治疗结束后,比较两组患者治疗前后血小板计数变化情况,探讨联合用药的临床应用价值。结果治疗后两组患者的血小板数量均有所提高,差异有统计学意义(P<0.05),提示两种治疗方法的有效性,而观察组血小板数量增加数明显高于对照组,差异有统计学意义(P<0.05),提示观察组联合用药的优越性。结论采用长春地辛及白介素-11联合治疗难治性特发性血小板减少性紫癜临床疗效满意,值得进一步推广应用。
作者 戴静
出处 《中国实用医药》 2014年第8期190-191,共2页 China Practical Medicine
  • 相关文献

参考文献1

二级参考文献14

  • 1RODEGHIERO F,STASI R,GERNSHEIMER T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113:2386-2393.
  • 2GUPTA R,SOUPIR C P,JOHARI V,et al.Myelodysplastic syndrome with isolated deletion of chromosome 20q:an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation[J].Br J Haematol,2007,139:265-268.
  • 3VESELY S K,PERDUE J J,RIZVI M A,et al.Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy:a systematic review[J].Ann Intern Med,2004,140:112-120.
  • 4BURZYNSKI J.New options after first-line therapy for chronic immune thrombocytopenic purpura[J].Am J Health Syst Pharm,2009,66:S11-21.
  • 5DIERICKX D,VERHOEF G,VAN HOOF A,et al.Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura:a Belgian retrospective multicentric study[J].J Intern Med,2009,266:484-491.
  • 6COOPER N,STASI R,CUNNINGHAM-RUNDLES S,et al.The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura[J].Br J Haematol,2004,125:232-239.
  • 7PENALVER F J,JIMENEZ-YUSTE V,ALMAGRO M,et al.Rituximab in the management of chronic immune thrombocytopenic purpura:an effective and safe therapeutic alternative in refractory patients[J].Ann Hematol,2006,85:400-406.
  • 8STASI R,PAGANO A,STIPA E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952-957.
  • 9BENNETT C M,ROGERS Z R,KINNAMON D D,et al.Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura[J].Blood,2006,107:2639-2642.
  • 10PASA S,ALTINTAS A,CIL T,et al.The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura[J].J Thromb Thrombolysis,2009,27:329-333.

共引文献14

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部